Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia

JA Pulikkan, V Dengler… - Blood, The Journal …, 2010 - ashpublications.org
JA Pulikkan, V Dengler, PS Peramangalam, AA Peer Zada, C Müller-Tidow, SK Bohlander…
Blood, The Journal of the American Society of Hematology, 2010ashpublications.org
Transcription factor CCAAT enhancer binding protein α (C/EBPα) is essential for
granulopoiesis and its function is deregulated in leukemia. Inhibition of E2F1, the master
regulator of cell-cycle progression, by C/EBPα is pivotal for granulopoiesis. Recent studies
show microRNA-223 (miR-223), a transcriptional target of C/EBPα, as a critical player during
granulopoiesis. In this report, we demonstrate that during granulopoiesis microRNA-223
targets E2F1. E2F1 protein was up-regulated in miR-223 null mice. We show that miR-223 …
Abstract
Transcription factor CCAAT enhancer binding protein α (C/EBPα) is essential for granulopoiesis and its function is deregulated in leukemia. Inhibition of E2F1, the master regulator of cell-cycle progression, by C/EBPα is pivotal for granulopoiesis. Recent studies show microRNA-223 (miR-223), a transcriptional target of C/EBPα, as a critical player during granulopoiesis. In this report, we demonstrate that during granulopoiesis microRNA-223 targets E2F1. E2F1 protein was up-regulated in miR-223 null mice. We show that miR-223 blocks cell-cycle progression in myeloid cells. miR-223 is down-regulated in different subtypes of acute myeloid leukemia (AML). We further show that E2F1 binds to the miR-223 promoter in AML blast cells and inhibits miR-223 transcription, suggesting that E2F1 is a transcriptional repressor of the miR-223 gene in AML. Our study supports a molecular network involving miR-223, C/EBPα, and E2F1 as major components of the granulocyte differentiation program, which is deregulated in AML.
ashpublications.org